Streetbeat News

Stock Prices

CAT

Caterpillar stock is recovering from a downturn in the mining sector, making it an attractive buy according to Barron's. The article suggests that the company's prospects are improving, which could lead to a positive impact on its stock price.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 12:20 pm

LGCY

Legacy Education Inc. has announced the pricing of its $10 million initial public offering, with shares priced at $4 each. The company plans to use the proceeds for facility investments, new program development, and general working capital. The shares will trade on the NYSE American under the symbol 'LGCY'.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 12:19 pm

TSHA

Taysha Gene Therapies is set to present clinical data on TSHA-102 for Rett Syndrome at the 9th World Rett Syndrome Congress in October. This presentation could provide insights into the progress and potential of their gene therapy treatment.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 12:18 pm

INMB

INmune Bio's INKmune has shown excellent safety and increased NK-cell activity in the first dosing cohort of its Phase I/II trial for metastatic castration-resistant prostate cancer (mCRPC).

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 12:17 pm

BTCUSD

Anthony Pompliano predicts Bitcoin will benefit from increased global liquidity due to recent monetary policy changes, including a Federal Reserve interest rate cut. He highlights Bitcoin's sensitivity to liquidity changes and notes that over 50% of Bitcoin is held long-term.

Portfolio Pulse from Murtuza Merchant

September 26, 2024 | 12:17 pm

MDXH

MDxHealth shares declined following the announcement of a $40 million offering, pricing 20 million shares at $2.00 each.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 12:17 pm

CHPT

ChargePoint (NYSE:CHPT) is focusing on future trends and innovations in the EV charging industry to maintain its leadership. The company is developing products for all market segments and classifications of electric vehicles.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 12:17 pm

CRVO

CervoMed Inc. (NASDAQ:CRVO) will present findings on neflamapimod for treating dementia with Lewy bodies at the 17th Clinical Trials on Alzheimer's Disease Conference in 2024.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 12:16 pm

NCNA

NuCana's shares have risen following the announcement of a U.S. patent grant for its NUC-7738 composition-of-matter.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 12:15 pm

LFVN

LifeVantage has completed a successful 12-week clinical trial on its new GLP-1 system for weight loss, showing positive results in weight management, reducing food cravings, and improving well-being.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 12:15 pm